HAL
Histidine ammonia-lyase
Also known as: HIS, HUTH_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P42357
- Gene
- HAL
- Ensembl
- ENSG00000084110
- Chromosome
- 12
- Canonical length
- 657 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Histidine ammonia-lyase is a cytosolic enzyme catalyzing the first reaction in histidine catabolism, the nonoxidative deamination of L-histidine to trans-urocanic acid. Histidine ammonia-lyase defects cause histidinemia which is characterized by increased histidine and histamine and decreased urocanic acid in body fluids. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
Canonical amino-acid sequenceUniProt
657 residues, UniProt reviewed canonical sequence.
>P42357|HAL
1 MPRYTVHVRG EWLAVPCQDA QLTVGWLGRE AVRRYIKNKP DNGGFTSVDD AHFLVRRCKG
61 LGLLDNEDRL EVALENNEFV EVVIEGDAMS PDFIPSQPEG VYLYSKYREP EKYIELDGDR
121 LTTEDLVNLG KGRYKIKLTP TAEKRVQKSR EVIDSIIKEK TVVYGITTGF GKFARTVIPI
181 NKLQELQVNL VRSHSSGVGK PLSPERCRML LALRINVLAK GYSGISLETL KQVIEMFNAS
241 CLPYVPEKGT VGASGDLAPL SHLALGLVGE GKMWSPKSGW ADAKYVLEAH GLKPVILKPK
301 EGLALINGTQ MITSLGCEAV ERASAIARQA DIVAALTLEV LKGTTKAFDT DIHALRPHRG
361 QIEVAFRFRS LLDSDHHPSE IAESHRFCDR VQDAYTLRCC PQVHGVVNDT IAFVKNIITT
421 ELNSATDNPM VFANRGETVS GGNFHGEYPA KALDYLAIGI HELAAISERR IERLCNPSLS
481 ELPAFLVAEG GLNSGFMIAH CTAAALVSEN KALCHPSSVD SLSTSAATED HVSMGGWAAR
541 KALRVIEHVE QVLAIELLAA CQGIEFLRPL KTTTPLEKVY DLVRSVVRPW IKDRFMAPDI
601 EAAHRLLLEQ KVWEVAAPYI EKYRMEHIPE SRPLSPTAFS LQFLHKKSTK IPESEDLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HAL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 184 nTPM
Expression across tissuesHPA
Tissue
- liver: 184 nTPM
- skin: 58 nTPM
- bone marrow: 11 nTPM
- spleen: 7.3 nTPM
- cervix: 3.6 nTPM
- pituitary gland: 3 nTPM
Single-cell type
- neutrophils: 341 nCPM
- hepatocytes: 175 nCPM
- neutrophil progenitors: 48 nCPM
- monocyte progenitors: 46 nCPM
- endometrial glandular cells: 35 nCPM
- somatotrophs: 24 nCPM
Immune cell
- neutrophil: 74 nTPM
- basophil: 57 nTPM
- classical monocyte: 15 nTPM
- non-classical monocyte: 14 nTPM
- intermediate monocyte: 5.7 nTPM
- total PBMC: 4.4 nTPM
Brain region
- cerebral cortex: 1 nTPM
- white matter: 0.4 nTPM
- cerebellum: 0.3 nTPM
- choroid plexus: 0.3 nTPM
- hypothalamus: 0.3 nTPM
- midbrain: 0.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HAL.
Disease | AllUniProt
Conditions HAL is implicated in, by any mechanism.
- Histidinemia (HISTID) MIM:235800
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 213 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Histidinemia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.31
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.26
- DepMap mean gene effect
- -0.18
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- L-histidine catabolic process
- L-histidine catabolic process to glutamate and formamide
- L-histidine catabolic process to glutamate and formate
Molecular functions
- histidine ammonia-lyase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- L-Aspartase-like
- Fumarase/histidase, N-terminal
- Aromatic amino acid lyase
- Histidine ammonia-lyase
- Phenylalanine/histidine ammonia-lyases, active site
- Aromatic amino acid lyase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HAL as an antibody target. Whether an autoantibody or antibody against HAL could matter depends on whether native HAL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HAL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HAL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...